Monthly Archives: June 2011

2011.06.29 Advocates Concerned that FDA Decision on Avastin and Breast Cancer Will Harm Women with Ovarian Cancer

Posted on June 29, 2011 by Abby

Washington, DC— Today, a panel of experts convened by the Food and Drug Administration (FDA) unanimously recommended that the label for Avastin (bevacizumab) no longer include metastatic breast cancer. The panel voted on four questions: if clinical trials on Avastin … Continue reading →

Posted in News, Press Releases | 2 Comments

Chemo Dosing Influences Drug Resistance

Posted on June 29, 2011 by Cara

A mouse study showed that continuous treatment with docetaxel (Taxotere) showed greater anti-tumor effects than treating the mice once a week or once every three weeks. Additionally, treating less often led to genetic changes that may lead to drug resistance. … Continue reading →

Posted in News | Tagged , , , , , | 1 Comment

2011.6.28 Ovarian Cancer National Alliance Urges FDA Not to Limit Access to Avastin (Bevacizumab) for Women with Ovarian Cancer

Posted on June 28, 2011 by ekirch

FOR IMMEDIATE RELEASE June 28, 2011 Ovarian Cancer National Alliance Urges FDA Not to Limit Access to Avastin (Bevacizumab) for Women with Ovarian Cancer  Washington, DC—On Tuesday, June 28, Dr. Robert Burger testified before a Food and Drug Administration (FDA) … Continue reading →

Posted in Press Releases | 1 Comment

Dr. Robert Burger Testifies Before FDA Panel About Avastin and Ovarian Cancer Treatment

Posted on June 28, 2011 by adavis

Update: On June 29, the FDA Oncologic Drugs Advisory Committee voted unanimously to remove metastatic breast cancer from the label for Avastin. Read a response from the Ovarian Cancer National Alliance. Dr. Robert Burger testified today before a Food and … Continue reading →

Posted in Blog | 1 Comment

2011.4.13 Statement about Decrease in Ovarian Cancer Deaths

Posted on June 27, 2011 by ekirch

FOR IMMEDIATE RELEASE April 19, 2011 Advocates Say Decline in Ovarian Cancer Deaths is “Right Direction, but Far Too Slow” Washington, DC—In April, the Journal of the National Cancer Institute published its Annual Report to the Nation of the Status … Continue reading →

Posted in Press Releases | 1 Comment

2011.6.22 Ovarian Cancer Survivor Testifies in Support of DoD Research Program

Posted on June 27, 2011 by ekirch

FOR IMMEDIATE RELEASE June 22, 2011 Ovarian Cancer Survivor Testifies in Support of DoD Research Program Washington, DC—Ovarian cancer survivor Susan Leighton testified today before the Senate Appropriations Subcommittee on Defense as a representative of the Ovarian Cancer National Alliance. … Continue reading →

Posted in Press Releases | Leave a comment

2011.7.9 Ovarian Cancer National Alliance Annual Conference

Posted on June 27, 2011 by ekirch

MEDIA ADVISORY WHAT The Ovarian Cancer National Alliance Annual Conference brings hundreds of women with ovarian cancer, researchers and caregivers to Washington, DC. This year’s conference features presentations on groundbreaking ovarian cancer research, strategies for coping with cancer, and a … Continue reading →

Posted in Press Releases | 1 Comment

2011.06.22 Susan Leighton Testifies in Support of DoD Ovarian Cancer Research Program

Posted on June 27, 2011 by ekirch

Ovarian cancer survivor Susan Leighton testified today before the Senate Appropriations Subcommittee on Defense, speaking on behalf of the Ovarian Cancer National Alliance. In her statement, Susan talked about the benefits of the Department of Defense Ovarian Cancer Research Program … Continue reading →

Posted in Press Releases | Leave a comment

2011.7.10 NED Concert Benefitting the Ovarian Cancer National Alliance

Posted on June 27, 2011 by ekirch

MEDIA ADVISORY  WHAT   Join the Ovarian Cancer National Alliance and hundreds of women with ovarian cancer for a unique benefit concert. The alternative rock band N.E.D. (which stands for No Evidence of Disease) is made up of gynecologic oncologists from … Continue reading →

Posted in Press Releases | 1 Comment

Chemotherapy Drug Shortages include Taxol

Posted on June 24, 2011 by Cara

Drug shortages around the country are affecting cancer patients. Recently ABC news covered the paclitaxel (brand name: Taxol)  shortage. Many cite the low cost of generic drugs as the cause of shortages. See the full article here

Posted in News | Tagged , , | 1 Comment

Meta-analysis Shows Exposure to Asbestos may Cause Ovarian Cancer

Posted on June 23, 2011 by Cara

A meta-analysis of 16 studies showed that a statistically signficant number of women with ovarian cancer had been exposed to asbestos. Red the full abstract here

Posted in News | Tagged , | 1 Comment

Susan Leighton Testifies in Support of DoD Ovarian Cancer Research Program

Posted on June 22, 2011 by adavis

Ovarian cancer survivor Susan Leighton testified today before the Senate Appropriations Subcommittee on Defense, speaking on behalf of the Ovarian Cancer National Alliance. In her statement, Susan talked about the benefits of the Department of Defense Ovarian Cancer Research Program … Continue reading →

Posted in Blog | Leave a comment